Rainmed Medical Limited
2297.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$214.41M
Close$
$-0.14
189.1% downside
Current Fair Value
189.1% downsideOvervalued by 189.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $214.41 Million |
|---|---|
| Enterprise Value | $403.48 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.06 |
| Beta | 0.57 |
| Outstanding Shares | 1,291,938,000 |
Return
| Return on Equity | -51.76% |
|---|---|
| Return on Assets | -30.06% |
| Return on Invested Capital | -29.22% |
Valuation & Multiples
| P/E Ratio | -2.66 |
|---|---|
| PEG | 8.42 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.62 |
| Enterprise Value to EBIT | -2.83 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.49 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Rainmed Medical Limited
208 employees
CEO: Yonghui Lyu Rainmed Medical Limited is a medical technology firm specializing in the creation, development, and market launch of advanced systems that utilize coronary angiography to assess fractional flow reserve (FFR) and the index of microvascula...